G. Schmid
Impact in
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
-
- Cancer-related Molecular Pathways
- Lymphatic System and Diseases
- PARP inhibition in cancer therapy
Papers in
- Oncology 4
- Cancer-related Molecular Pathways 3
- Lymphatic System and Diseases 1
-
- Telomeres, Telomerase, and Senescence 2
- Co-authors
- Józefa Węsierska‐Gądek (5 shared papers)Markus Otto Guba (2 shared papers)Christiane J. Bruns (2 shared papers)Christian Graeb (2 shared papers)K.‐W. Jauch (2 shared papers)Ralf Huss (1 shared paper)Patrick Christian Hermann (1 shared paper)Christopher Heeschen (1 shared paper)
In The Last Decade
G. Schmid
8 papers receiving 369 citations
Peers
Comparison fields: 5 of 51
- Transplantation 43
- Oncology 150
- Aging 8
- Geriatrics and Gerontology 7
- Molecular Biology 102
Countries citing papers authored by G. Schmid
This map shows the geographic impact of G. Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Schmid more than expected).
Fields of papers citing papers by G. Schmid
This network shows the impact of papers produced by G. Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Schmid. The network helps show where G. Schmid may publish in the future.
Co-authors
The 21 scholars most cited alongside G. Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 180 | |
| 2 | Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts. | 1999 | 47 |
| 3 | Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein. | 2001 | 37 |
| 4 | 2005 | 35 | |
| 5 | 2000 | 29 | |
| 6 | Physiological ageing: role of p53 and PARP-1 tumor suppressors in the regulation of terminal senescence. | 2005 | 23 |
| 7 | Role of p53 tumor suppressor in ageing: regulation of transient cell cycle arrest and terminal senescence. | 2005 | 21 |
| 8 | 1995 | 6 |
About G. Schmid
G. Schmid is a scholar working on Oncology, Physiology, Molecular Biology, Artificial Intelligence and Nuclear Energy and Engineering, having authored 8 papers that have together received 378 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Telomeres, Telomerase, and Senescence (2 papers), AI-based Problem Solving and Planning (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Lymphatic System and Diseases (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Transplantation (43 citations), Oncology (150 citations), Aging (8 citations), Geriatrics and Gerontology (7 citations) and Molecular Biology (102 citations). G. Schmid has collaborated with scholars based in Austria and Germany. Frequent co-authors include Józefa Węsierska‐Gądek, Markus Otto Guba, Christiane J. Bruns, Christian Graeb, K.‐W. Jauch, Ralf Huss, Patrick Christian Hermann, Christopher Heeschen, Stephan L. Huber and Claudius H. Conrad. Their work appears in journals such as Kidney International, Oncogene, Transplantation Proceedings, Lecture notes in computer science and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.